Flexion Therapeutics Inc (FLXN) is a publicly traded company in the Unknown sector. Across all available filings, 32 corporate insiders have executed 314 transactions totaling $76.0M, demonstrating a bullish sentiment with $60.8M in net insider flow. The most recent transaction on Nov 19, 2021 involved a transaction of 388,683 shares valued at $3.3M.
No significant insider buying has been recorded for FLXN in the recent period.
No significant insider selling has been recorded for FLXN in the recent period.
Based on recent SEC filings, insider sentiment for FLXN is bullish with an Insider Alignment Score of 90/100 and a net flow of $60.8M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at Flexion Therapeutics Inc (FLXN) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 32 insiders are actively trading FLXN stock, having executed 314 transactions in the past 90 days. The most active insider is Samuel D. Colella (Executive), who has made 36 transactions totaling $28.0M.
Get notified when executives and directors at FLXN file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 19, 2021 | D. Clayman Michael | Executive | Disposition | 388,683 | $8.50 | $3.3M | Large |
| Nov 19, 2021 | D. Clayman Michael | Executive | Disposition | 24,600 | $8.50 | $209.1K | |
| Nov 19, 2021 | D. Clayman Michael | Executive | Disposition | 373,769 | $8.50 | $3.2M | Large |
| Nov 19, 2021 | D. Clayman Michael | Executive | Disposition | 335,498 | $8.50 | $2.9M | Large |
| Nov 19, 2021 | T. Andrews William | Executive | Disposition | 34,250 | $8.50 | $291.1K | |
| Nov 19, 2021 | W. Driscoll Frederick | Executive | Disposition | 30,680 | $8.50 | $260.8K | |
| Nov 19, 2021 | Willwerth Christina | Executive | Disposition | 141,241 | $8.50 | $1.2M | Large |
| Nov 19, 2021 | Layman Melissa | Executive | Disposition | 103,956 | $8.50 | $883.6K | Large |
| Nov 19, 2021 | Wentworth Kerry | Executive | Disposition | 140,843 | $8.50 | $1.2M | Large |
| Nov 19, 2021 | Wentworth Kerry | Executive | Disposition | 6,000 | $8.50 | $51.0K | |
| Nov 19, 2021 | Muzikant Adam | Executive | Disposition | 103,666 | $8.50 | $881.2K | Large |
| Nov 19, 2021 | S. Levine Mark | Executive | Disposition | 133,486 | $8.50 | $1.1M | Large |
| Nov 19, 2021 | J. Mahaffy Patrick | Executive | Disposition | 39,824 | $8.50 | $338.5K | |
| Nov 19, 2021 | A. Canute Scott | Executive | Disposition | 9,000 | $8.50 | $76.5K | |
| Nov 19, 2021 | D. Colella Samuel | Executive | Disposition | 994,129 | $8.50 | $8.5M | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 62 | $68.4M | 64.1% |
Disposition(D) | 29 | $29.2M | 27.4% |
Sale(S) | 54 | $7.6M | 7.1% |
Payment(F) | 15 | $621.1K | 0.6% |
Exercise(M) | 20 | $368.3K | 0.3% |
Other(J) | 24 | $189.2K | 0.2% |
Award(A) | 66 | $155.9K | 0.1% |
Exercise (Options)(X) | 2 | $79.2K | 0.1% |
Tender(U) | 1 | $0 | 0.0% |
Gift(G) | 19 | $0 | 0.0% |
Conversion(C) | 22 | $0 | 0.0% |
Insiders at Flexion Therapeutics Inc are accumulating shares at an accelerated pace. With 32 insiders making 314 transactions totaling $68.4M in purchases versus $7.6M in sales, the net buying activity of $60.8M signals strong executive confidence. Samuel D. Colella (Executive) leads the buying activity with $28.0M in transactions across all time.